Baccharis Allergy Shots (SCIT)
Baccharis allergy shots (SCIT) target a salt-tolerant coastal marsh shrub whose male plants release wind-dispersed pollen October through November — weeks after ragweed season ends — creating a sequential two-punch fall allergy calendar for patients from Charleston to Galveston. The conspicuous fluffy white plumes patients see in fall are female seed structures, not the allergenic pollen.
Baccharis Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to baccharis — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of baccharis allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of baccharis immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of baccharis extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for baccharis allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing baccharis extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription baccharis immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat baccharis allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Baccharis?
The biology, taxonomy, and clinical fingerprint of Baccharis — the foundation of how SCIT targets it.
Baccharis halimifolia female plants produce conspicuous fluffy white seed plumes in fall — these are seeds, not pollen; the wind-borne pollen is released by separate male plants in late September through November
- Scientific name
- Baccharis halimifolia
- Family
- AsteraceaeComposite / Daisy family
- Type
- Dioecious perennial shrub pollen
- Native to
- Atlantic and Gulf Coast brackish-marsh zones, Massachusetts to Texas
- Allergen proteins
- No WHO/IUIS-characterized allergens for Baccharis spp.Modern literature essentially limited to extract-level skin prick test data — molecular research extremely sparseWestern relative B. salicifolia (mule fat) bimodal pollen season in coastal Southern California and Sonoran Desert riparian zones
- Particle size
- N/A — uncharacterized
- Avoidance difficulty
- Very difficult
How Baccharis Allergy Presents
Symptoms by body system — useful for distinguishing Baccharis sensitivity from overlapping allergies and infections.
Respiratory
- Late-fall rhinitis October through November for Atlantic and Gulf coastal residents — beginning after ragweed season has ended
- Nasal congestion and sneezing in Mobile, Charleston, Savannah, Tampa, Galveston, and Brownsville during October–November
- Allergic asthma exacerbation in the late-fall period for coastal patients who thought their season was ending
- Post-nasal drip and throat clearing persisting into November and sometimes December on the Gulf Coast
- Symptoms intensified for patients living within 1–2 miles of tidal marsh or brackish coastal wetlands
Ocular
- Allergic conjunctivitis October–November in coastal SE and Gulf patients
- Bilateral tearing and itching coinciding with the transition from ragweed to baccharis season
- Symptoms continuing when patients expect fall allergy to resolve after ragweed peak
- Higher exposure near coastal marshes, tidal flats, and salt-spray roadsides
Skin
- Potential Asteraceae sesquiterpene lactone contact dermatitis from direct plant handling
- Atopic dermatitis flare during the October–November coastal pollen peak
- OAS from Asteraceae pan-allergens uncharacterized but theoretically possible
Systemic
- Fatigue and sleep disruption from prolonged coastal fall allergy — the sequential ragweed (Aug–Sept) then baccharis (Oct–Nov) pattern creates a 3–4 month continuous season
- Holiday-season symptoms in coastal SE/Gulf states that surprise patients expecting fall allergy season to have ended
- Baccharis is invasive in coastal Australia and parts of Europe — expanding global allergological relevance
- Patients within 1–2 miles of tidal marsh have substantially higher cumulative exposure
When a Charleston patient still has nasal symptoms in November after ragweed counts have dropped to zero, baccharis is usually the answer — and they are looking at it bloom right outside their door without knowing what it is.
When & Where Baccharis Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: October through November on Atlantic seaboard; extending into December on the Gulf Coast· ~8–10 weeks of pollen release from male plants; the sequential ragweed + baccharis pattern creates a 3–4 month total coastal fall allergy season
US Exposure Map
7 high-intensity statesWhat Baccharis Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Baccharis is in tribe Astereae (same tribe as goldenrod and asters) — but unlike goldenrod, B. halimifolia is wind-pollinated and a legitimate aeroallergen; molecular cross-reactivity data are absent due to uncharacterized allergens, but clinical co-sensitization with ragweed, dog-fennel, and marshelder is high in coastal Southeast patients.
Sequential coastal season — ragweed August–September, baccharis October–November; co-sensitization common in Gulf patients
Both extend the Southeast fall season; often co-included in Gulf coastal fall-weed vials
Is SCIT Right for Your Baccharis Allergy?
Answer five questions to assess whether baccharis SCIT is likely appropriate for your Atlantic or Gulf Coast fall allergy profile.
Do you live within a few miles of the Atlantic or Gulf Coast, particularly near marshes, tidal flats, or salt-spray roadsides?
The Baccharis SCIT Protocol
Baccharis SCIT uses non-standardized B. halimifolia extract (W/V labeled); no WHO/IUIS allergens are characterized and no SCIT-specific RCT has been published. Clinical use in coastal Southeast allergy practices combines it in a Gulf/Atlantic late-fall-weed vial with short ragweed, dog-fennel, marshelder, and cocklebur.
Progressive dose escalation with mandatory 30-minute post-injection observation. Build-up initiated by June allows approaching maintenance before the September–October baccharis onset. The baccharis component is combined with ragweed, dog-fennel, and marshelder in a coastal fall-weed vial.
Monthly maintenance injections. The October–November symptom window is the primary endpoint for confirming baccharis component effectiveness. Perennial maintenance is appropriate for coastal Louisiana and Florida patients with extended seasons.
After successful completion, durable tolerance is expected. Patients in coastal areas with continuing high exposure may benefit from extended maintenance.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Baccharis SCIT
No published RCT evaluates SCIT specifically for Baccharis halimifolia. Clinical use rests on documented sensitization rates in coastal Southeast populations and the general AAAAI/ACAAI Practice Parameter framework (Cox 2011) for non-standardized weed SCIT.
- Sensitization rate in coastal SE/Gulf fall-symptomatic adults11%Regional NAB / Gulf-Atlantic coastal allergy clinic data — 8–14% of fall-symptomatic adults show positive baccharis reactivity
- Weeks by which baccharis extends the fall allergy season beyond ragweed6%Regional aerobiological monitoring — sequential ragweed (Aug–Sept) then baccharis (Oct–Nov) pattern documented in Atlantic and Gulf Coast NAB stations; 6–8 week season extension
No baccharis-specific SCIT RCT has been published. The evidence base is limited to sensitization data and aerobiology. The clinical value proposition is clear — extending fall allergy treatment coverage to the October–November window that standardized ragweed products (Ragwitek) cannot address — but patients should be informed of the limited evidence before starting therapy.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Baccharis SCIT Side Effects
Baccharis SCIT follows the standard inhalant SCIT safety profile with mandatory 30-minute post-injection observation.
Local reactions
4 documentedSystemic reactions
4 documentedBaccharis SCIT safety is consistent with the general inhalant SCIT record; no baccharis-specific safety concerns beyond standard protocol requirements have been identified.
SCIT vs Alternatives for Baccharis
Coastal patients with baccharis sensitization and extended fall symptoms typically receive a combined coastal fall-weed SCIT vial rather than baccharis alone, available at home through Curex; generic SLIT drops or medications are the main alternatives.
| Criterion | At-Home SCIT (Curex)Best | SLIT drops/tablets | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Extrapolated — no baccharis RCT | Extrapolated evidence | Very difficult — dominant coastal marsh shrub | Symptom suppression only |
| 5-yr cost | $3,500–$8,000 out-of-pocket | Daily drops (varies by pharmacy) | Low direct cost | $300–$1,200/year |
| Duration | 3–5 years | 3–5 years | Seasonal | Daily in season |
| Convenience | At-home self-injection; weekly then monthly | Daily drops at home | Restricts coastal outdoor activity Oct–Nov | Convenient but 3–4 month burden |
| Safety | Systemic reaction <0.01%/injection | Lower systemic risk | Complete | Well-tolerated |
| Lasting effect | Durable benefit expected | Durable benefit expected | No lasting effect | No lasting effect |
At-Home SCIT (Curex)Best
SLIT drops/tablets
Avoidance
Medications
For coastal patients in low-population ZIP codes from Apalachicola to Cameron Parish who are far from allergy clinics, Curex delivers an at-home allergy shot at $129/month all-inclusive — a personalized serum compounded to USP <797> covering the complete coastal Gulf/Atlantic fall-weed complex including baccharis, ragweed, dog-fennel, and marshelder in a single formulation, with a prescribed epinephrine auto-injector confirmed on hand and the first injection plus every dose change supervised live over Zoom by a board-certified allergist — no weekly clinic trips required.
What Baccharis SCIT Actually Costs
Baccharis SCIT as a component of a coastal fall-weed vial is typically covered under standard allergy immunotherapy benefits when a board-certified allergist documents sensitization; coverage depends on plan deductible and co-insurance. Curex at-home IgE testing identifies specific baccharis sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your baccharis allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Baccharis SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
The conspicuous fluffy white silk-like plumes that cover baccharis (groundsel-tree) shrubs in October and November are FEMALE seed structures — achenes with silky pappus hairs that help seeds disperse by wind. They are NOT the allergenic component. Baccharis is dioecious — male and female flowers occur on separate plants. The actual allergenic pollen is released by male plants in late September through November and is not visually distinctive. Many patients blame the white fluffy plumes for their allergy, not realizing they are looking at seeds while being exposed to invisible pollen from nearby male plants.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.